Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose Ignacio Martin

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
American Journal of Human Genetics|February 9, 2010
Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndromeReinhard Schneppenheim, Michael C Frühwald, Stefan Gesk, et al.
Human Pathology|May 31, 2006
BCL6 alternative breakpoint region break and homozygous deletion of 17q24 in the nodular lymphocyte predominance type of Hodgkin's lymphoma-derived cell line DEVCiğdem Atayar, Klaas Kok, Joost Kluiver, et al.
Blood|April 5, 2003
Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphomaHongtao Ye, Hongxiang Liu, Ayoma Attygalle, et al.
JAMA Neurology|May 31, 2017
Complex and Dynamic Chromosomal Rearrangements in a Family With Seemingly Non-Mendelian Inheritance of Dopa-Responsive DystoniaKatja Lohmann, Claire Redin, Holger Tönnies, et al.
Therapeutic Advances in Medical Oncology|January 9, 2025
Real-world effectiveness and safety of second- or third-line pegylated liposomal irinotecan plus 5-fluorouracil and folinic acid in pancreatic ductal adenocarcinoma in SpainRafael Álvarez-Gallego, Roberto Pazo-Cid, Borja López de San Vicente, et al.
Epilepsia|April 14, 2010
Deletions in 16p13 including GRIN2A in patients with intellectual disability, various dysmorphic features, and seizure disorders of the rolandic regionConstanze Reutlinger, Ingo Helbig, Barbara Gawelczyk, et al.
Chemmedchem|August 13, 2009
Optimization of thienopyrrole-based finger-loop inhibitors of the hepatitis C virus NS5B polymeraseJose Ignacio Martin Hernando, Jesus Maria Ontoria, Savina Malancona, et al.
Journal of Medicinal Chemistry|October 1, 2019
Development of Chemical Entities Endowed with Potent Fast-Killing Properties against <i>Plasmodium falciparum</i> Malaria ParasitesAlexios N Matralis, Adnan Malik, Maria Penzo, et al.
Journal of Neuropathology and Experimental Neurology|March 16, 2007
Transcriptional profiling of the nuclear factor-kappaB pathway identifies a subgroup of primary lymphoma of the central nervous system with low BCL10 expressionCornelius Courts, Manuel Montesinos-Rongen, Jose Ignacio Martin-Subero, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2011
Identification of MK-5710 ((8aS)-8a-methyl-1,3-dioxo-2-[(1S,2R)-2-phenylcyclo- propyl]-N-(1-phenyl-1H-pyrazol-5-yl)hexahydro-imidazo[1,5-a]pyrazine-7(1H)-carboxamide), a potent smoothened antagonist for use in Hedgehog pathway dependent malignancies, part 2Olaf Kinzel, Anna Alfieri, Sergio Altamura, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
American Journal of Human Genetics|February 9, 2010
Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndromeReinhard Schneppenheim, Michael C Frühwald, Stefan Gesk, et al.
Human Pathology|May 31, 2006
BCL6 alternative breakpoint region break and homozygous deletion of 17q24 in the nodular lymphocyte predominance type of Hodgkin's lymphoma-derived cell line DEVCiğdem Atayar, Klaas Kok, Joost Kluiver, et al.
Blood|April 5, 2003
Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphomaHongtao Ye, Hongxiang Liu, Ayoma Attygalle, et al.
JAMA Neurology|May 31, 2017
Complex and Dynamic Chromosomal Rearrangements in a Family With Seemingly Non-Mendelian Inheritance of Dopa-Responsive DystoniaKatja Lohmann, Claire Redin, Holger Tönnies, et al.
Therapeutic Advances in Medical Oncology|January 9, 2025
Real-world effectiveness and safety of second- or third-line pegylated liposomal irinotecan plus 5-fluorouracil and folinic acid in pancreatic ductal adenocarcinoma in SpainRafael Álvarez-Gallego, Roberto Pazo-Cid, Borja López de San Vicente, et al.
Epilepsia|April 14, 2010
Deletions in 16p13 including GRIN2A in patients with intellectual disability, various dysmorphic features, and seizure disorders of the rolandic regionConstanze Reutlinger, Ingo Helbig, Barbara Gawelczyk, et al.
Chemmedchem|August 13, 2009
Optimization of thienopyrrole-based finger-loop inhibitors of the hepatitis C virus NS5B polymeraseJose Ignacio Martin Hernando, Jesus Maria Ontoria, Savina Malancona, et al.
Journal of Medicinal Chemistry|October 1, 2019
Development of Chemical Entities Endowed with Potent Fast-Killing Properties against <i>Plasmodium falciparum</i> Malaria ParasitesAlexios N Matralis, Adnan Malik, Maria Penzo, et al.
Journal of Neuropathology and Experimental Neurology|March 16, 2007
Transcriptional profiling of the nuclear factor-kappaB pathway identifies a subgroup of primary lymphoma of the central nervous system with low BCL10 expressionCornelius Courts, Manuel Montesinos-Rongen, Jose Ignacio Martin-Subero, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2011
Identification of MK-5710 ((8aS)-8a-methyl-1,3-dioxo-2-[(1S,2R)-2-phenylcyclo- propyl]-N-(1-phenyl-1H-pyrazol-5-yl)hexahydro-imidazo[1,5-a]pyrazine-7(1H)-carboxamide), a potent smoothened antagonist for use in Hedgehog pathway dependent malignancies, part 2Olaf Kinzel, Anna Alfieri, Sergio Altamura, et al.
Pageof 4